These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37065097)

  • 21. Combination of a liquid fibrin sealant with sheet-type hemostatic agents: experimental evaluation in partial nephrectomy animal model.
    Ishii K; Kawashima H; Hayama T; Asai T; Kamikawa S; Sakamoto W; Miyabashira S; Oka S; Sugimoto T
    Int J Urol; 2011 Jun; 18(6):478-82. PubMed ID: 21488977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemostats, sealants, and adhesives: components of the surgical toolbox.
    Spotnitz WD; Burks S
    Transfusion; 2008 Jul; 48(7):1502-16. PubMed ID: 18422855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the Hemostatic Efficacy of Two Powdered Topical Absorbable Hemostats Using a Porcine Liver Abrasion Model of Mild to Moderate Bleeding.
    MacDonald MH; Tasse L; Wang D; Zhang G; De Leon H; Kocharian R
    J Invest Surg; 2021 Nov; 34(11):1198-1206. PubMed ID: 32928005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemostatic Agents and Tissue Sealants: Potential Mimics of Abdominal Abnormalities.
    Morani AC; Platt JF; Thomas AJ; Kaza RK; Al-Hawary MM; Cohan RH; Francis IR; Elsayes KM
    AJR Am J Roentgenol; 2018 Oct; 211(4):760-766. PubMed ID: 30063381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hospital economic impact from hemostatic matrix usage in cardiac surgery.
    Tackett SM; Sugarman R; Kreuwel HT; Alvarez P; Nasso G
    J Med Econ; 2014 Sep; 17(9):670-6. PubMed ID: 24927164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of fibrin sealants in orthopaedic surgery.
    Thoms RJ; Marwin SE
    J Am Acad Orthop Surg; 2009 Dec; 17(12):727-36. PubMed ID: 19948697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative evaluation of absorbable hemostats: advantages of fibrin-based sheets.
    Krishnan LK; Mohanty M; Umashankar PR; Lal AV
    Biomaterials; 2004 Nov; 25(24):5557-63. PubMed ID: 15142738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet-Inspired Intravenous Nanomedicine for Injury-Targeted Direct Delivery of Thrombin to Augment Hemostasis in Coagulopathies.
    Girish A; Jolly K; Alsaadi N; de la Fuente M; Recchione A; An R; Disharoon D; Secunda Z; Raghunathan S; Luc NF; Desai C; Knauss E; Han X; Hu K; Wang H; Sekhon UDS; Rohner N; Gurkan UA; Nieman M; Neal MD; Sen Gupta A
    ACS Nano; 2022 Oct; 16(10):16292-16313. PubMed ID: 35916497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemostasis and hemostatic agents in minimally invasive surgery.
    de la Torre RA; Bachman SL; Wheeler AA; Bartow KN; Scott JS
    Surgery; 2007 Oct; 142(4 Suppl):S39-45. PubMed ID: 18019941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemostatic agents and instruments in laparoscopic renal surgery.
    Msezane LP; Katz MH; Gofrit ON; Shalhav AL; Zorn KC
    J Endourol; 2008 Mar; 22(3):403-8. PubMed ID: 18355135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical hemostatic agents: assessment of drugs and medical devices.
    Aubourg R; Putzolu J; Bouche S; Galmiche H; Denis C; d'Andon A; Maitrot D; Partensky C
    J Visc Surg; 2011 Dec; 148(6):e405-8. PubMed ID: 22136914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biosurgical Hemostatic Agents in Neurosurgical Intracranial Procedures.
    Gazzeri R; Galarza M; Callovini G; Alfieri A
    Surg Technol Int; 2017 Feb; 30():468-476. PubMed ID: 28182825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthetic Strategies for Engineering Intravenous Hemostats.
    Chan LW; White NJ; Pun SH
    Bioconjug Chem; 2015 Jul; 26(7):1224-36. PubMed ID: 25803791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of fibrin sealants in hemostasis.
    Mankad PS; Codispoti M
    Am J Surg; 2001 Aug; 182(2 Suppl):21S-28S. PubMed ID: 11566473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An in vivo comparison of the efficacy of hemostatic powders, using two porcine bleeding models.
    MacDonald MH; Wang AY; Clymer JW; Hutchinson RW; Kocharian R
    Med Devices (Auckl); 2017; 10():273-279. PubMed ID: 29238233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemostatic Comparison of a Polysaccharide Powder and a Gelatin Powder.
    Singh RK; Baumgartner B; Mantei JR; Parreno RN; Sanders PJ; Lewis KM; Barry JJ
    J Invest Surg; 2019 Aug; 32(5):393-401. PubMed ID: 29420097
    [No Abstract]   [Full Text] [Related]  

  • 37. Analysis of the hemostatic potential of modern topical sealants on arterial and venous anastomoses: an experimental porcine study.
    Fonouni H; Kashfi A; Majlesara A; Stahlheber O; Konstantinidis L; Kraus TW; Mehrabi A; Oweira H
    J Mater Sci Mater Med; 2017 Sep; 28(9):134. PubMed ID: 28755096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors Associated With Hemostatic Agent Use During Laparoscopic Hysterectomy.
    Kakos A; Allen V; Whiteside J
    J Minim Invasive Gynecol; 2016; 23(7):1167-1171. PubMed ID: 27590570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymeric Hydrogel Systems as Emerging Biomaterial Platforms to Enable Hemostasis and Wound Healing.
    Pourshahrestani S; Zeimaran E; Kadri NA; Mutlu N; Boccaccini AR
    Adv Healthc Mater; 2020 Oct; 9(20):e2000905. PubMed ID: 32940025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravenous Hemostats: Foundation, Targeting, and Controlled-Release.
    Chen Z; Han L; Meng G; Li H; Shan C; Du G; Li M
    Bioconjug Chem; 2022 Dec; 33(12):2269-2289. PubMed ID: 36404605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.